Navigation Links
Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient

PHILADELPHIA, Oct. 26 /PRNewswire/ -- Pleio Health Support Systems, Inc. (Pleio) announces updated results of the Pleio GoodStart(TM) medication adherence program. Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart(TM) had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).

Data also showed that patients who participated in the GoodStart(TM) program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart(TM) program.

"Improving people's experience with new prescription medications involves many disciplines. Pleio's technology, pharmacy and manufacturer partners are equally dedicated to improving the patient experience with new prescriptions. These results show that when elderly patients are carefully listened to, stimulated in language they can relate to, and empowered with performance support, adherence challenges are easily overcome."

Pleio GoodStart connects physicians, patients, pharmacies, families and pharmaceutical manufacturers toward their common goal of improved patient adherence. Physicians gain the assurance that their patients will be well-supported and that future patient appointments can be more effective. Pharmacies are provided a new perspective on C&P through training and feedback on patient progress. Patients receive unprecedented interest in their welfare throughout the medication adoption phase, with up to 75 contacts during their first 100 days on therapy. Family and friend support is stimulated through awareness of the issue of adherence and their potential to be an advocate.

About Pleio Health Support Systems, Inc.

Pleio Health Supports Systems, founded in 2006, has offices in Montreal and Boston. Pleio GoodStart(TM) is a sponsored adherence program that helps patients properly adopt new medications and in turn refill more prescriptions over a longer period of time. Pleio GoodStart(TM) is a registered trademark of Pleio Health Support Systems, Inc. For more information, visit or contact Jean Lalonde, at (514) 369-9995 info(at)

SOURCE Pleio Health Support Systems, Inc.

SOURCE Pleio Health Support Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
2. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
3. Patients Receiving High Radiation at Cedars Sinai File Class Action Lawsuit
4. Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
5. Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers
6. ULORIC(R) (febuxostat) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout
7. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
8. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
9. New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone
10. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
11. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
Post Your Comments:
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... YORK , Sept. 12, 2017   EcoVadis , the leading ... has published the first annual edition of its Global CSR Risk and ... companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 ... ... Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
Breaking Medicine News(10 mins):